Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:cyclophosphamide/fluorouracil/vincristine'
(id=7141974 ; fe=en:cyclophosphamide/fluorouracil/vincristine ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1809 creation date=2017-06-25 touchdate=2025-07-25 00:28:23.000)
≈ 35 relations sortantes

  1. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 39 / 1 -> en:cof protocol
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:cof protocol | rel=r_associated | relid=0 | w=39
  2. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 34 / 0.872 -> en:cyclophosphamide
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=34
  3. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 30 / 0.769 -> fluorouracile
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=fluorouracile | rel=r_associated | relid=0 | w=30
  4. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 28 / 0.718 -> en:drug/agent combination
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:drug/agent combination | rel=r_associated | relid=0 | w=28
  5. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 26 / 0.667 -> en:fluorouracil
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:fluorouracil | rel=r_associated | relid=0 | w=26
  6. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 26 / 0.667 -> en:haemato fu
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:haemato fu | rel=r_associated | relid=0 | w=26
  7. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> 5 FU
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=5 FU | rel=r_associated | relid=0 | w=20
  8. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> cyclophosphamide
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=cyclophosphamide | rel=r_associated | relid=0 | w=20
  9. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:adenovirus 5-cd40 ligand
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:adenovirus 5-cd40 ligand | rel=r_associated | relid=0 | w=20
  10. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:altretamine/cisplatin/cyclophosphamide/doxorubicin
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:altretamine/cisplatin/cyclophosphamide/doxorubicin | rel=r_associated | relid=0 | w=20
  11. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:altretamine/cyclophosphamide/methotrexate
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:altretamine/cyclophosphamide/methotrexate | rel=r_associated | relid=0 | w=20
  12. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:altretamine/etoposide/methotrexate
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:altretamine/etoposide/methotrexate | rel=r_associated | relid=0 | w=20
  13. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:amphotericin b/colistin sulfate/tobramycin
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:amphotericin b/colistin sulfate/tobramycin | rel=r_associated | relid=0 | w=20
  14. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:asparaginase/daunorubicin/prednisone/vincristine
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:asparaginase/daunorubicin/prednisone/vincristine | rel=r_associated | relid=0 | w=20
  15. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:bleomycin/cisplatin/cyclophosphamide/dactinomycin/vinblastine
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:bleomycin/cisplatin/cyclophosphamide/dactinomycin/vinblastine | rel=r_associated | relid=0 | w=20
  16. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:bleomycin/cisplatin/ifosfamide
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:bleomycin/cisplatin/ifosfamide | rel=r_associated | relid=0 | w=20
  17. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:bleomycin/cyclophosphamide/dexamethasone/doxorubicin/vincristine
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:bleomycin/cyclophosphamide/dexamethasone/doxorubicin/vincristine | rel=r_associated | relid=0 | w=20
  18. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:bleomycin/doxorubicin/mechlorethamine/methotrexate/vincristine
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:bleomycin/doxorubicin/mechlorethamine/methotrexate/vincristine | rel=r_associated | relid=0 | w=20
  19. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:caffeine/cisplatin/cytarabine
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:caffeine/cisplatin/cytarabine | rel=r_associated | relid=0 | w=20
  20. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:carmustine/cisplatin/dacarbazine
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:carmustine/cisplatin/dacarbazine | rel=r_associated | relid=0 | w=20
  21. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:carmustine/cytarabine/etoposide/melphalan
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:carmustine/cytarabine/etoposide/melphalan | rel=r_associated | relid=0 | w=20
  22. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:cisplatin/cyclophosphamide/doxorubicin/triazinate
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:cisplatin/cyclophosphamide/doxorubicin/triazinate | rel=r_associated | relid=0 | w=20
  23. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:cisplatin/cyclophosphamide/vindesine
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:cisplatin/cyclophosphamide/vindesine | rel=r_associated | relid=0 | w=20
  24. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:copp regimen
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:copp regimen | rel=r_associated | relid=0 | w=20
  25. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:cyclophosphamide/doxorubicin/lomustine/vincristine
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:cyclophosphamide/doxorubicin/lomustine/vincristine | rel=r_associated | relid=0 | w=20
  26. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:cytarabine/daunorubicin/mercaptopurine/prednisolone
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:cytarabine/daunorubicin/mercaptopurine/prednisolone | rel=r_associated | relid=0 | w=20
  27. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:cytarabine/doxorubicin/prednisone/vincristine
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:cytarabine/doxorubicin/prednisone/vincristine | rel=r_associated | relid=0 | w=20
  28. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:cytarabine/etoposide/mitoxantrone
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:cytarabine/etoposide/mitoxantrone | rel=r_associated | relid=0 | w=20
  29. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:doxorubicin/etoposide/vinblastine
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:doxorubicin/etoposide/vinblastine | rel=r_associated | relid=0 | w=20
  30. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:fluoro-uracile
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:fluoro-uracile | rel=r_associated | relid=0 | w=20
  31. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:human papillomavirus 16 e7 peptide/padre 965.10
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:human papillomavirus 16 e7 peptide/padre 965.10 | rel=r_associated | relid=0 | w=20
  32. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:melphalan/thiotepa
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:melphalan/thiotepa | rel=r_associated | relid=0 | w=20
  33. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> en:ny-eso-1 protein vaccine plus montanide isa-51 vg
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:ny-eso-1 protein vaccine plus montanide isa-51 vg | rel=r_associated | relid=0 | w=20
  34. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 20 / 0.513 -> fluoro-uracile
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=fluoro-uracile | rel=r_associated | relid=0 | w=20
  35. en:cyclophosphamide/fluorouracil/vincristine -- r_associated #0: 1 / 0.026 -> en:therapeutic or preventive procedure
    n1=en:cyclophosphamide/fluorouracil/vincristine | n2=en:therapeutic or preventive procedure | rel=r_associated | relid=0 | w=1
≈ 45 relations entrantes

  1. fluorouracile --- r_associated #0: 254 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=fluorouracile | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=254
  2. en:fluorouracil --- r_associated #0: 253 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:fluorouracil | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=253
  3. en:haemato fu --- r_associated #0: 239 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:haemato fu | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=239
  4. en:cisplatin/cyclophosphamide/doxorubicin/triazinate --- r_associated #0: 43 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:cisplatin/cyclophosphamide/doxorubicin/triazinate | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=43
  5. en:cisplatin/cyclophosphamide/vindesine --- r_associated #0: 43 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:cisplatin/cyclophosphamide/vindesine | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=43
  6. en:altretamine/cyclophosphamide/methotrexate --- r_associated #0: 41 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:altretamine/cyclophosphamide/methotrexate | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=41
  7. fluoro-uracile --- r_associated #0: 36 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=fluoro-uracile | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=36
  8. en:adenovirus 5-cd40 ligand --- r_associated #0: 35 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:adenovirus 5-cd40 ligand | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=35
  9. en:cytarabine/daunorubicin/mercaptopurine/prednisolone --- r_associated #0: 35 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:cytarabine/daunorubicin/mercaptopurine/prednisolone | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=35
  10. en:cytarabine/etoposide/mitoxantrone --- r_associated #0: 35 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:cytarabine/etoposide/mitoxantrone | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=35
  11. en:bleomycin/cisplatin/cyclophosphamide/dactinomycin/vinblastine --- r_associated #0: 34 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:bleomycin/cisplatin/cyclophosphamide/dactinomycin/vinblastine | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=34
  12. en:carmustine/cisplatin/dacarbazine --- r_associated #0: 34 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:carmustine/cisplatin/dacarbazine | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=34
  13. en:carmustine/cytarabine/etoposide/melphalan --- r_associated #0: 34 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:carmustine/cytarabine/etoposide/melphalan | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=34
  14. en:asparaginase/daunorubicin/prednisone/vincristine --- r_associated #0: 32 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:asparaginase/daunorubicin/prednisone/vincristine | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=32
  15. en:bleomycin/cisplatin/ifosfamide --- r_associated #0: 32 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:bleomycin/cisplatin/ifosfamide | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=32
  16. en:cof protocol --- r_associated #0: 32 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:cof protocol | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=32
  17. en:cytarabine/doxorubicin/prednisone/vincristine --- r_associated #0: 31 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:cytarabine/doxorubicin/prednisone/vincristine | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=31
  18. en:amphotericin b/colistin sulfate/tobramycin --- r_associated #0: 30 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:amphotericin b/colistin sulfate/tobramycin | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=30
  19. en:fluoro-uracile --- r_associated #0: 30 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:fluoro-uracile | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=30
  20. en:melphalan/thiotepa --- r_associated #0: 30 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:melphalan/thiotepa | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=30
  21. en:ny-eso-1 protein vaccine plus montanide isa-51 vg --- r_associated #0: 30 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:ny-eso-1 protein vaccine plus montanide isa-51 vg | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=30
  22. en:bleomycin/cyclophosphamide/dexamethasone/doxorubicin/vincristine --- r_associated #0: 29 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:bleomycin/cyclophosphamide/dexamethasone/doxorubicin/vincristine | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=29
  23. en:cyclophosphamide/doxorubicin/lomustine/vincristine --- r_associated #0: 29 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:cyclophosphamide/doxorubicin/lomustine/vincristine | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=29
  24. 5 FU --- r_associated #0: 28 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=5 FU | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=28
  25. en:altretamine/etoposide/methotrexate --- r_associated #0: 28 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:altretamine/etoposide/methotrexate | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=28
  26. en:altretamine/cisplatin/cyclophosphamide/doxorubicin --- r_associated #0: 27 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:altretamine/cisplatin/cyclophosphamide/doxorubicin | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=27
  27. en:caffeine/cisplatin/cytarabine --- r_associated #0: 27 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:caffeine/cisplatin/cytarabine | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=27
  28. en:copp regimen --- r_associated #0: 27 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:copp regimen | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=27
  29. cyclophosphamide --- r_associated #0: 26 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=cyclophosphamide | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=26
  30. en:bleomycin/doxorubicin/mechlorethamine/methotrexate/vincristine --- r_associated #0: 26 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:bleomycin/doxorubicin/mechlorethamine/methotrexate/vincristine | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=26
  31. en:cyclophosphamide --- r_associated #0: 26 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:cyclophosphamide | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=26
  32. en:doxorubicin/etoposide/vinblastine --- r_associated #0: 26 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:doxorubicin/etoposide/vinblastine | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=26
  33. en:human papillomavirus 16 e7 peptide/padre 965.10 --- r_associated #0: 26 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:human papillomavirus 16 e7 peptide/padre 965.10 | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=26
  34. en:drug/agent combination --- r_associated #0: 20 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:drug/agent combination | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=20
  35. cyclope (oeil) --- r_associated #0: 15 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=cyclope (oeil) | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=15
  36. fluorescence induite par la tétracycline (test de) --- r_associated #0: 15 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=fluorescence induite par la tétracycline (test de) | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=15
  37. 5 fluoro-uracile --- r_associated #0: 10 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=5 fluoro-uracile | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=10
  38. Cyclophosphamide --- r_associated #0: 10 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=Cyclophosphamide | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=10
  39. Fluorouracile --- r_associated #0: 10 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=Fluorouracile | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=10
  40. en:cyclops eye --- r_associated #0: 10 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:cyclops eye | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=10
  41. en:tetracyclin-induced fluorescence test --- r_associated #0: 10 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=en:tetracyclin-induced fluorescence test | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=10
  42. cyclopeptide --- r_associated #0: 5 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=cyclopeptide | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=5
  43. cyclophiline --- r_associated #0: 5 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=cyclophiline | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=5
  44. cyclophorie --- r_associated #0: 5 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=cyclophorie | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=5
  45. fluoro --- r_associated #0: 5 --> en:cyclophosphamide/fluorouracil/vincristine
    n1=fluoro | n2=en:cyclophosphamide/fluorouracil/vincristine | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr